机构：[1]Institute of Thoracic Oncology and Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[2]Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, Sichuan, China.[3]Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
第一作者机构：[1]Institute of Thoracic Oncology and Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.[2]Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, Sichuan, China.
通讯作者：
通讯机构：[1]Institute of Thoracic Oncology and Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.[2]Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, Sichuan, China.[*1]Institute of Thoracic Oncology and Department of Thoracic Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan 610041, China.
推荐引用方式(GB/T 7714)：
Xia Liang,Chen Weizhi,Liu Lunxu.Perioperative ctDNA-Based MRD Detection in NSCLC-Response[J].Clinical cancer research : an official journal of the American Association for Cancer Research.2022,28(15):3401.doi:10.1158/1078-0432.CCR-22-1226.
APA：
Xia Liang,Chen Weizhi&Liu Lunxu.(2022).Perioperative ctDNA-Based MRD Detection in NSCLC-Response.Clinical cancer research : an official journal of the American Association for Cancer Research,28,(15)
MLA：
Xia Liang,et al."Perioperative ctDNA-Based MRD Detection in NSCLC-Response".Clinical cancer research : an official journal of the American Association for Cancer Research 28..15(2022):3401
医学